Steris plcSTE

Health Care · Health Care Equipment & Services · NYSE · Ireland · steris.com

STERIS plc is a global provider of infection prevention, sterilization, and surgical products and services, serving healthcare, pharmaceutical, and industrial customers worldwide. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences, offering sterilization services, surgical and contamination prevention products, and laboratory testing services. STERIS is legally incorporated in Dublin, Ireland, with operational headquarters in Mentor, Ohio.

Key ratios

Operating cash flow growth

1.9%TTM

2026 16.8%2025 18.0%2024 28.6%

EPS growth

25.1%TTM

2026 28.7%2025 11.0%2024 -0.2%

FCF / Sales

15.3%TTM

2026 16.4%2025 14.3%2024 11.9%2023 8.7%

Net margin

13.3%TTM

2026 13.2%2025 11.3%2024 7.4%2023 2.4%

ROA

6.8%TTM

2026 6.7%2025 5.8%2024 5.2%2023 4.6%

ROE

11.4%TTM

2026 11.4%2025 9.5%2024 8.9%2023 8.8%

Revenue growth

8.4%TTM

2026 8.7%2025 6.2%2024 13.3%

Recent news

STERIS to Present at the Morgan Stanley Healthcare Conference 2026-09-01 · GlobeNewswire STERIS Announces Financial Results for Fiscal 2027 First Quarter 2026-08-05 · GlobeNewswire STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina 2026-08-05 · GlobeNewswire STERIS Raises Dividend to $0.69 per share 2026-07-30 · GlobeNewswire STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year 2026-05-11 · GlobeNewswire Pierre Boulud joins STERIS (NYSE: STE) board as company expands seats 2026-05-07 · StockTitan

Track STE in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer